Integrating novel therapies into the management of moderate-to-severe ulcerative colitis: challenges and opportunities

被引：2
|
作者：
Ma, Christopher [1 ]
Choi, May Y. [1 ]
机构：
[1] Mayo Clin, Dept Gastroenterol & Hepatol, Phoenix, AZ 85054 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2022年 / 7卷 / 02期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1016/S2468-1253(21)00432-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：110 / 112
页数：3
相关论文
共 50 条
  • [1] Etrolizumab in moderate-to-severe ulcerative colitis
    Armuzzi, Alessandro
    Felice, Carla
    LANCET, 2014, 384 (9940) : 285 - 286
  • [2] An evaluation of risankizumab for the treatment of moderate-to-severe ulcerative colitis
    Johnson, Amanda M.
    Loftus Jr, Edward V.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (12) : 1317 - 1327
  • [3] Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis
    Miyoshi, Jun
    Matsuura, Minoru
    Hisamatsu, Tadakazu
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 1 - 8
  • [4] Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies
    Jairath, Vipul
    Afif, Waqqas
    Bressler, Brian
    Pope, Janet E.
    Selchen, Daniel
    Targownik, Laura E.
    Panaccione, Remo
    JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2024, 7 (04) : 282 - 289
  • [5] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Feagan, Brian G.
    Schreiber, Stefan
    Wolf, Douglas C.
    Axler, Jeffrey L.
    Kaviya, Arpeat
    James, Alexandra
    Curtis, Rebecca I.
    Geransar, Parnia
    Stallmach, Andreas
    Ehehalt, Robert
    Bokemeyer, Bernd
    Khalid, Javaria Mona
    O'Byrne, Sharon
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1028 - 1035
  • [6] Therapeutic options for children and young people with moderate-to-severe ulcerative colitis
    Ashton, James
    Lee, Kwang Yang
    Thangarajah, Anthi
    Rodrigues, Astor
    Kammermeier, Jochen
    FRONTLINE GASTROENTEROLOGY, 2024, 15 (05) : 387 - 394
  • [7] Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block
    Fiorino, Gionata
    Allocca, Mariangela
    Correale, Carmen
    Roda, Giulia
    Furfaro, Federica
    Loy, Laura
    Zilli, Alessandra
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (04) : 421 - 427
  • [8] Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis
    Ananthakrishnan, Ashwin N.
    Murad, M. Hassan
    Scott, Frank I.
    Agrawal, Manasi
    Haydek, John P.
    Limketkai, Berkeley N.
    Loftus, Edward V., Jr.
    Singh, Siddharth
    GASTROENTEROLOGY, 2024, 167 (07) : 1460 - 1482
  • [9] AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
    Singh, Siddharth
    Loftus Jr, Edward, V
    Limketkai, Berkeley N.
    Haydek, John P.
    Agrawal, Manasi
    Scott, Frank I.
    Ananthakrishnan, Ashwin N.
    GASTROENTEROLOGY, 2024, 167 (07) : 1307 - 1343
  • [10] Medical therapy versus surgery in moderate-to-severe ulcerative colitis
    Fiorino, Gionata
    Danese, Silvio
    Giacobazzi, Giovanni
    Spinelli, Antonino
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (04) : 403 - 408
12345